Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Icon Plc (ICLR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,770,215
  • Shares Outstanding, K 54,080
  • Annual Sales, $ 1,758 M
  • Annual Income, $ 281,490 K
  • 36-Month Beta 0.40
  • Price/Sales 4.41
  • Price/Cash Flow 21.72
  • Price/Book 6.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 1.54
  • Number of Estimates 9
  • High Estimate 1.56
  • Low Estimate 1.50
  • Prior Year 1.35
  • Growth Rate Est. (year over year) +14.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
132.01 +8.84%
on 07/27/18
149.69 -4.01%
on 08/10/18
+6.47 (+4.72%)
since 07/17/18
3-Month
118.31 +21.44%
on 05/18/18
149.69 -4.01%
on 08/10/18
+20.42 (+16.57%)
since 05/17/18
52-Week
101.22 +41.95%
on 02/06/18
149.69 -4.01%
on 08/10/18
+38.49 (+36.59%)
since 08/17/17

Most Recent Stories

More News
ICON Reports Second Quarter 2018 Results

--Excluding the impact of ASC 606, record net business wins in the quarter of $600 million; a book to bill of 1.27.

ICLR : 143.68 (+0.23%)
ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions...

ICLR : 143.68 (+0.23%)
OncoCyte (OCX) in Focus: Stock Moves 13.1% Higher

OncoCyte (OCX) was a big mover last session, as the company saw its shares rise more than 13% on the day.

ICLR : 143.68 (+0.23%)
OCX : 2.35 (-7.84%)
ICON Is Collaborating with Practice Fusion, Inc. to Advance Health Research

ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and medical device industries, today announced that it is working with Practice...

ICLR : 143.68 (+0.23%)
ICON Enhances Endpoint Adjudication Services Using AG Mednet Advanced Technology

ICON plc (NASDAQ: ICLR), a global provider of drug development and commercialisation solutions and services, today announced it has signed an agreement with AG Mednet to use Judi,...

ICLR : 143.68 (+0.23%)
Investor Expectations to Drive Momentum within Momo, Barrick Gold, Grupo Financiero Santander Mexico S.A. B. de C.V., DBV Technologies S.A., ICON, and SCIENCE APPLICATIONS INTERNATIONAL CORPORATION -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Momo Inc. (NASDAQ:MOMO), Barrick...

MOMO : 38.15 (+1.60%)
ICLR : 143.68 (+0.23%)
BSMX : 7.75 (+0.26%)
DBVT : 18.80 (+2.23%)
ABX : 10.02 (+1.62%)
SAIC : 88.99 (+1.41%)
ICON Announces Agreement with Intel Allowing Integration of the Intel(R) Pharma Analytics Platform for Clinical Trials

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed...

ICLR : 143.68 (+0.23%)
Detailed Research: Economic Perspectives on ICON, Melco Resorts & Entertainment, Kornit Digital, MercadoLibre, Logitech International S.A, and SK Telecom Co. -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ICON PLC (NASDAQ:ICLR), Melco...

MELI : 324.20 (-3.17%)
ICLR : 143.68 (+0.23%)
SKM : 25.79 (-1.45%)
LOGI : 46.88 (+0.88%)
KRNT : 18.60 (+0.27%)
MLCO : 22.10 (+2.65%)
ICON Announces Launch of Government and Public Health Solutions to Support Global Public Health

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the rebranding of...

ICLR : 143.68 (+0.23%)
Dr Debra Lerner selects Mapi Research Trust as exclusive distributor and Mapi Language Services as exclusive translator of the Work Limitations Questionnaire (WLQ)

Mapi Research Trust, the leading curator and license distributor of Clinical Outcome Assessments (COAs) and Mapi Language Services, part of ICON plc and a leader in linguistic validation, have been appointed...

ICLR : 143.68 (+0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ICLR with:

Business Summary

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

See More

Key Turning Points

2nd Resistance Point 145.55
1st Resistance Point 144.62
Last Price 143.68
1st Support Level 142.13
2nd Support Level 140.57

See More

52-Week High 149.69
Last Price 143.68
Fibonacci 61.8% 131.17
Fibonacci 50% 125.46
Fibonacci 38.2% 119.74
52-Week Low 101.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar